Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

AI Meets Oncology: New Model Personalizes Bladder Cancer Treatment

bladder cancer

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging and gene expression analyses in a way that outperforms previous models using a single data type.

The study, published March 22 in npj Digital Medicine, identifies key genes and tumor characteristics that may determine treatment success. The ability to accurately anticipate how an individual will react to the standard-of-care therapy for this malignant cancer may help doctors personalize treatment and could potentially save those who respond well from undergoing bladder removal.

WCM-Q Students Celebrate Successful Match Day

five students holding signs during a celebration

Graduating Weill Cornell Medicine-Qatar medical students joined their New York City counterparts during Match Day on March 21 to learn where they matched for their residencies.

Weill Cornell Medicine-Qatar achieved a 93% match rate for those who applied to U.S. residency programs, exceeding the average 59% match rate for international medical graduates. Five WCM-Q students, including Mohammad Yaghmour, matched to WCM-affiliated NewYork-Presbyterian campuses.

“Studying at WCM-Q has really been the best of both worlds,” said Yaghmour, who matched to NewYork-Presbyterian/Weill Cornell Medical Center for a residency in general surgery. “You get to access the prestigious education system of the U.S. while being able to stay around your own family, which is everything that I could have asked for. I am very grateful and if I had my time again I would definitely make the same choice to study at WCM-Q.”

Read the full story on WCM-Q’s website.

 

 

$50 Million Gift from the Weill Family Foundation Establishes the Weill Cancer Hub East

Five men standing together for a group photo

New York, N.Y., and Princeton, N.J. (March 27, 2025)—With a mission to understand how nutrition and metabolism impact the body’s ability to control cancer, four leading research institutions have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment. The initiative connects world-class experts from Princeton University, The Rockefeller University, Weill Cornell Medicine and the Ludwig Institute for Cancer Research to enhance a therapeutic strategy known as immunotherapy that harnesses a patient’s own immune cells to treat cancer. Immunotherapy holds much promise, but its effectiveness varies in different people and against different types of cancer.

The Weill Cancer Hub East was established with a transformational $50 million gift from the Weill Family Foundation, directed by visionary benefactors Joan and Sanford I. Weill, and matched with philanthropy from each partner institution that together will total more than $125 million. The initiative seeks to break down institutional barriers and unite top experts in cancer biology, cancer clinical trials, immunology, nutrition and metabolism to drive pioneering, cross-field collaboration that pushes the boundaries of scientific discovery.

Contact Us